Synageva BioPharma Corp (NASDAQ:GEVA)

108.51
Delayed Data
As of Apr 24
 +0.92 / +0.86%
Today’s Change
60.19
Today|||52-Week Range
122.88
+16.94%
Year-to-Date
No recent news for Synageva BioPharma Corp.

Today’s Trading

Previous close107.59
Today’s open106.95
Day’s range-- - --
Volume305,982
Average volume (3 months)302,768
Market cap$4.0B
Dividend yield--
Data as of 04/24/2015

Growth & Valuation

Earnings growth (last year)-73.24%
Earnings growth (this year)-27.52%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-51.46%
P/E ratioNM
Price/Sales467.65
Price/Book7.65

Competitors

 Today’s
change
Today’s
% change
CTLTCatalent Inc-0.05-0.16%
BLUEbluebird bio Inc-3.82-2.73%
XONIntrexon Corp-0.91-2.02%
JUNOJuno Therapeutics In...-1.06-1.84%
Data as of 04/24/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$1.71
Annual revenue (last year)$6.5M
Annual profit (last year)-$192.6M
Net profit margin-2,967.47%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Operating Officer
Robert B. Bazemore
Corporate headquarters
Lexington, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers